This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
AstraZeneca’s Daiichi Sankyo-partnered antibody-drug conjugate Enhertu has made it onto China’s national insurance program despite the star med being a part of an ongoing investigation in the count | AstraZeneca’s Daiichi Sankyo-partnered antibody-drug conjugate Enhertu has made it onto China’s national insurance program despite the star med being (..)
Commercial insurers’ practices, such as prior authorization and white bagging, are needed to reduce costs for patients, said Kristine Grow, senior vice president of communications at AHIP.
America’s Health Insurance Plans’ new campaign aims to show how health insurers are working to create savings for Americans while also targeting Big Pharma (or more specifically drug manufacturers) for increasing drug costs. The ads will be distributed on TV, social media and streaming services.
Merck has reportedly settled with insurance companies that contested the pharma giant’s $1.4 Merck has settled with insurance companies that contested the pharma giant’s $1.4 billion claim after it was victimized by a crippling cyberattack in 2017.
Right now, annual raises are being neutralized by increasing healthcare insurance premiums. If pharma wants to retain people, they may have to develop a solution to lower healthcare insurance premiums. The average per-employee cost of employer-sponsored health insurance jumped 6.3 Employers in the U.S. percent and 5.2
2023 is shaping up to be a crucial year for everyone involved – and affected – by the pharmaceutical industry. It’s likely to be a year of experimentation for payers – and defensiveness for drug makers.
drug prices, the role of insurers and pharmacy benefit managers (PBMs) often commands at least some of the attention. | At the Senate committee hearing on Novo Nordisk's prices for Ozempic and Wegovy, debate around insurance coverage and pharmacy benefit managers took up much of the conversation.
HEY NOW : Most companies struggled in the second quarter as the coronavirus pandemic froze the economy, but health insurers like UnitedHealth heavily benefited as people held off on going to the doctor or hospital, resulting in fewer medical claims that needed to be paid. In addition, pharma profit margins remain very high.
We just finished talking to over 200 hundred HCPs about pharma marketing and salespeople to measure any differences since before the pandemic. Trust in pharma did not decline, but they don’t want to be told about the data via charts; they want the ability to read the data for themselves and talk to other HCPs about the data and drug.
Nationwide, prescription drug spending last year is estimated to be $328 billion among all payers, including private insurance, Medicare Part D, and patients’ out-of-pocket expenses. Still, the pharma industry is fighting hard to keep it off the table. Pharma is a very profitable industry.
scored a legal win in the insurance case tied to the 2017 "NotPetya" cyberattack, the case is in appeals—again. scored a legal win in the insurance case tied to the 2017 "NotPetya" cyberattack, the case is in appeals—again. About a month and a half after Merck & Co. That didn't take long.
last year gave away more than $23 billion in rebates to insurance intermediaries, but still netted $50 billion in sales. drug pricing system is filled with confusing numbers , and many entities profit off the flow of drugs, but pharmaceutical companies retain a vast majority of the proceeds” Big pharma IS big business.
Multiple efforts are underway to improve cell therapies for cancer. During the MedCity News INVEST conference in Chicago, a panel discussed the future of cell therapies and what the industry doing to manage the financial risks of these new treatments.
AstraZeneca has found its employees’ practices under the microscope of Chinese law enforcement years after an insurance fraud case. AstraZeneca has found its employees’ practices under the microscope of Chinese law enforcement years after an insurance fraud case.
Such warnings “constitute the pharma response in literally every instance since 1906,” the first drug regulation agency was created, said Dr. Aaron Kesselheim. It also raises healthcare costs for public and private insurers alike. Of course, the drug industry warns that any price negotiation will kill innovation.
SUMMARY: The biggest argument against pharma is the cost of prescription drugs. Pharma could do something about this by simply uniting to make it easier for patients who can’t afford their medications to get them free or at little cost. It would, of course, be non-profit, and employees would be paid collectively by the industry.
THOUGHT: I love working in the pharma industry. The issue around drug pricing will remain a hot button in the media even though hospitals are making outrageous profits and insurers are again starting to deny patients recommended treatments. Every pharma CEO should require that every employee has a KRA on focusing on patients.
during Tuesday’s trading in London after a local report fueled fears of a potentially escalating insurance fraud investigation in China. during Tuesday’s trading in London after a report fueled fears of a potentially escalating insurance fraud investigation in China. AstraZeneca’s stock price dropped by 8.4%
Everyone, it seems, has issues with big pharma. From obscene profits to outrageous compensation for CEOs pharma has seems to have the attitude of a big corporation who doesn’t care. The question that everyone seems to be avoiding is “can pharma serve both Wall Street and patients?”
A partnership between Eisai and Lifenet that aims to improve insurance cover for people with early dementia has generated its first policy, part of an effort by the pharma group to develop an ‘ecosystem’ to support patients.
SUMMARY: The media loves to blame pharma companies for high healthcare costs, but unless we start to invest in healthy lifestyles, we’re headed for a healthcare crisis the likes of which we have never experienced. The media have targeted pharmaceutical companies for a long time because sensational headlines lead to clicks.
A bipartisan group of senators sent a letter to HHS asking it to rethink its appeal of a recent federal district court decision that limits the use of “copay accumulators” — which are programs insurers use to prevent medication copay assistance from counting toward patients’ deductibles or out-of-pocket maximums.
SUMMARY: People are going online more and more to sarch for health information after seeing a DTC pharma TV spot. Pharma websites are not consdiered a top resource for infromation on new products. Cost is not that big of an issue for people who have health insurance. Last year was an excellent year for our consulting group.
They told the researchers that insurance didn’t protect them from serious money problems. While 98% of them had insurance, 71% fell deeper into debt, took out a new loan, sold or refinanced a home, or experienced at least a 20% decline in income — or a combination of these over the year they answered quarterly surveys.
SUMMARY: I believe the biggest challenge facing pharma companies doesn’t come from legislation or R&D. Here are some suggestions on how, I believe, pharma can attract and keep great employees. So what can senior pharma executives do to make their company a great place to work for employees?
Introduction Pharma marketing is constantly evolving, with new digital tools, regulatory updates, and data-driven strategies shaping the industry. How do pharma marketing executives ensure they are using the best tools and strategies? However, with so much information available, finding the right resources can feel overwhelming.
With the decision, the company will proceed with a pricing strategy it believes will speed up insurance coverage and patient adoption of the new treatment for the chronic inflammatory skin disorder. The FDA approved Arcutis Biotherapeutics drug Zoryve, a topical treatment for plaque psoriasis.
The advancement, adoption of, and access to these options – regardless of age, geography, and financial considerations – requires the support of the scientific community, drug developers, funders, regulatory agencies, insurers, and lawmakers to make the concept of a hormone-free future a reality.
Of course, this comes at an increased cost even though health insurers are making a lot of money. Employees for the most part are happy with their health insurance but that happiness is going to come at a higher cost. The weight management services should be mandatory as obese employees are liable to cost companies and insurers more.
PhRMA has rounded up its attack ad team once again for another broadside against pharmacy benefit managers, zeroing in this time on the potential for insurers to profit from where prescriptions get | PhRMA has rounded up its attack ad team once again for another broadside against pharmacy benefit managers, zeroing in this time on the potential for (..)
Physicians and insurers are rejecting Aduhelm because it should never have been approved in the first place. Then they decided to move their HQ to an expensive campus in downtown Cambridge to play with “big pharma” Along with the move came new competitors and MS patients who reported that other MS drugs were better.
Insurance companies are trying to figure out how to pay for them. Cell and gene therapies are offering patients potentially curative treatments for a growing scope of diseases. Industry consultants speaking at the HLTH conference offered some strategies they see payers taking to these new therapies.
The Office of the Inspector General (OIG) of the Department of Health and Human Services (HHS) has published an unfavorable opinion in response to bluebird’s request for an advisory review of the program.
That information should be shared with HCPs and insurers to understand better the barriers and opportunities of treating patients. HCPs want to understand their patients better as insurers require better patient outcomes. A pharma company that silos DTC from HCP marketing people is disadvantaged. Business building concept.
So why is pharma wasting so much money? The question then becomes, “why are pharma brands still using them?” Still, it wasn’t practical because physicians wanted much more information, including insurance coverage and compliance issues. Research has shown that only 35% of digital display ads received views.
” When I stopped exercising because of a broken bone, I gained some weight, and my insurance company did send me a letter about the dangers of weight gain, but it was a form letter, and there was no follow-up. Where does pharma come into this battle?
According to the Kaiser Family Foundation (KFF), in 2021, the average cost of employee health insurance premiums for family coverage increased by 4% from the previous year to $22,221. health insurers report billions as small providers face stress in the first quarter. The answer may be in offering a value-based healthcare model.
When they say compare prescription drug prices, they mean the cost of a prescription if you aren’t using insurance. Supossidly Good Rx has “relationships” with most top pharma companies, but that relationship may be to say “hello.” And advertising? ” It’s not a coupon.
AstraZeneca and Gilead's ADCs passed on China's national insurance scheme. AstraZeneca and Gilead's ADCs passed on China's national insurance scheme. Bristol Myers Squibb inked an antibody-drug conjugate (ADC) licensing deal worth up to $8.4
For the past nine years, EVERSANA INTOUCH has done a look ahead: a forecast based on input from leaders on what trends may shape pharma marketing in the year ahead. Lets take a closer look at each of these trends: Applied AI: As excitement continues to grow and AI becomes more real, how is it being deployed by pharma marketers?
SUMMARY: According to eMarketer, “in 2020, spending on digital advertising in the healthcare and pharma industry will grow by 14.2% One area I do agree with them is that “healthcare and pharma will make up 7.1% One area I do agree with them is that “healthcare and pharma will make up 7.1% to reach $9.53
Millennium Pharma’s ad and website for ENTYVIO touch all the bases with targeted patients. ” The website has numerous patient resources, including links to support groups and financial information for those who need help determining if their insurance covers the treatment. “I need to be close to home and my bathroom.”
1ne : Physician expectations from pharma have shifted. They want pharma to “get to the point” and stop trying to “sell” so much. 2wo : Patients are becoming “customers” of healthcare as they pay more for health insurance. They expect and want more from HCPs and pharma companies.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content